Company Filing History:
Years Active: 2022-2023
Title: Jerrid Matson - Innovator in Antimicrobial Medical Devices
Introduction
Jerrid Matson is a notable inventor based in Champlin, MN (US). He has made significant contributions to the field of medical devices, particularly in the application of antimicrobial agents. With a total of 2 patents to his name, Matson's work focuses on enhancing patient safety through innovative technology.
Latest Patents
One of Jerrid Matson's latest patents involves the application of antimicrobial agents to medical devices. This invention includes invasive medical devices that feature a substantially non-eluting antimicrobial treatment. The design incorporates a copper-coated surface on one or more external and/or internal surfaces of the medical device, which helps prevent microbial colonization. This innovation significantly reduces the incidence of infections in patients that may arise from the medical device. In one embodiment, a catheter assembly is described, which consists of an elongate catheter tube defining at least one lumen, an extension leg with a luer connector, and a bifurcation hub that includes at least one fluid passageway for communication between the extension leg and the lumen. The copper coating is applied through an electroless deposition process, and a water-shed coating is placed on top of the copper coating to enhance its effectiveness.
Career Highlights
Jerrid Matson is currently employed at C. R. Bard, Inc., where he continues to develop innovative medical solutions. His work is instrumental in advancing the safety and efficacy of medical devices used in healthcare settings.
Collaborations
Matson collaborates with talented individuals such as Giridhar Thiagarajan and Murtaza Yusuf Amin, contributing to a dynamic team focused on innovation in medical technology.
Conclusion
Jerrid Matson's contributions to the field of medical devices, particularly through his patented innovations, demonstrate his commitment to improving patient care and safety. His work continues to influence the development of effective antimicrobial treatments in healthcare.